A Study of the Efficacy and Safety of Ranquilon Tablets in Patients With Anxiety in Neurasthenia and Adjustment Disorders

NCT05586789 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Anxiety
Neurasthenia
Adjustment Disorders

Interventions

DRUG: Ranquilon
DRUG: Placebo

Sponsor

Valenta Pharm JSC